Literature DB >> 31310775

Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.

Carolina L Haass-Koffler1, Victoria M Long2, Mehdi Farokhnia3, Molly Magill2, George A Kenna4, Robert M Swift5, Lorenzo Leggio6.   

Abstract

Increasing evidence supports the role of appetite-regulating hormones, including ghrelin, in alcohol use disorder (AUD). Effects of ghrelin administration on cortisol and aldosterone, two hormones known to influence the development and maintenance of AUD, have been observed in ghrelin-exposed tissues or cells, as well as rodents and healthy volunteers, however whether these effects replicate in individuals with AUD is unknown. Here, we tested the hypothesis that intravenous administration of ghrelin leads to increase in endogenous serum cortisol and aldosterone concentrations in alcohol-dependent, heavy drinking individuals, and that these changes may predict ghrelin-induced alcohol craving. This was a double-blind, placebo-controlled human laboratory study in non-treatment-seeking, heavy-drinking, alcohol-dependent individuals randomized to receive either placebo, 1 mcg/kg or 3 mcg/kg of intravenous ghrelin. Then, participants underwent a cue-reactivity procedure in a bar-like setting, which included exposure to both neutral (juice) and alcohol cues. Repeated blood samples were collected and used to measure endogenous cortisol and aldosterone serum concentrations, in response to exogenous ghrelin administration. Furthermore, cortisol and aldosterone serum concentrations were used to develop a model to predict the effect of exogenous ghrelin administration on alcohol craving. Intravenous ghrelin administration increased endogenous cortisol and aldosterone serum concentrations. While the effects on cortisol were greater than those on aldosterone, only the ghrelin-induced changes in aldosterone serum concentrations predicted craving. These findings provide initial evidence of ghrelin effects on glucocorticoids and mineralocorticoids in individuals with AUD, thereby providing additional information on the potential mechanisms by which the ghrelin system may play a role in alcohol craving and seeking in AUD.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol use disorder; Aldosterone; Cortisol; Craving; Ghrelin

Mesh:

Substances:

Year:  2019        PMID: 31310775      PMCID: PMC6745267          DOI: 10.1016/j.neuropharm.2019.107711

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

1.  Ways to fit a PK model with some data below the quantification limit.

Authors:  S L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

2.  Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals.

Authors:  M Farokhnia; E N Grodin; M R Lee; E N Oot; A N Blackburn; B L Stangl; M L Schwandt; L A Farinelli; R Momenan; V A Ramchandani; L Leggio
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

3.  Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.

Authors:  Alfonso Abizaid; Zhong-Wu Liu; Zane B Andrews; Marya Shanabrough; Erzsebet Borok; John D Elsworth; Robert H Roth; Mark W Sleeman; Marina R Picciotto; Matthias H Tschöp; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

4.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

5.  A role of ghrelin in neuroendocrine and behavioral responses to stress in mice.

Authors:  A Asakawa; A Inui; T Kaga; H Yuzuriha; T Nagata; M Fujimiya; G Katsuura; S Makino; M A Fujino; M Kasuga
Journal:  Neuroendocrinology       Date:  2001-09       Impact factor: 4.914

6.  Neurobiology of dysregulated motivational systems in drug addiction.

Authors:  Scott Edwards; George F Koob
Journal:  Future Neurol       Date:  2010-05-01

Review 7.  The Role of the Ghrelin System in Drug Addiction.

Authors:  Lia J Zallar; Mehdi Farokhnia; Brendan J Tunstall; Leandro F Vendruscolo; Lorenzo Leggio
Journal:  Int Rev Neurobiol       Date:  2017-09-18       Impact factor: 3.230

8.  Ghrelin stimulation by hypothalamic-pituitary-adrenal axis activation depends on increasing cortisol levels.

Authors:  I Azzam; S Gilad; R Limor; N Stern; Y Greenman
Journal:  Endocr Connect       Date:  2017-10-16       Impact factor: 3.335

Review 9.  Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence.

Authors:  B Adinoff; A Iranmanesh; J Veldhuis; L Fisher
Journal:  Alcohol Health Res World       Date:  1998

10.  Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving.

Authors:  C L Haass-Koffler; E G Aoun; R M Swift; S M de la Monte; G A Kenna; L Leggio
Journal:  Transl Psychiatry       Date:  2015-09-29       Impact factor: 6.222

View more
  6 in total

Review 1.  Gray areas: Neuropeptide circuits linking the Edinger-Westphal and Dorsal Raphe nuclei in addiction.

Authors:  Matthew B Pomrenze; Leigh C Walker; William J Giardino
Journal:  Neuropharmacology       Date:  2021-09-02       Impact factor: 5.273

2.  Effect of intravenous ghrelin administration, combined with alcohol, on circulating metabolome in heavy drinking individuals with alcohol use disorder.

Authors:  Olli Kärkkäinen; Mehdi Farokhnia; Anton Klåvus; Seppo Auriola; Marko Lehtonen; Sara L Deschaine; Daria Piacentino; Kelly M Abshire; Shelley N Jackson; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2021-09-30       Impact factor: 3.928

3.  Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors.

Authors:  Zhi-Bing You; Ewa Galaj; Francisco Alén; Bin Wang; Guo-Hua Bi; Allamar R Moore; Tristram Buck; Madeline Crissman; Sruti Pari; Zheng-Xiong Xi; Lorenzo Leggio; Roy A Wise; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2021-12-18       Impact factor: 8.294

4.  Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes.

Authors:  Hayan Jeong; Hyo-Jin Chong; Jangho So; Yejin Jo; Tae-Young Yune; Bong-Gun Ju
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

5.  Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Authors:  Mehdi Farokhnia; Kelly M Abshire; Aaron Hammer; Sara L Deschaine; Anitha Saravanakumar; Enoch Cobbina; Zhi-Bing You; Carolina L Haass-Koffler; Mary R Lee; Fatemeh Akhlaghi; Lorenzo Leggio
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

6.  Advances in understanding addiction treatment and recovery.

Authors:  Benjamin Xu; Kevin S LaBar
Journal:  Sci Adv       Date:  2019-10-16       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.